Fresenius Medical Care revenue and financials
€40.45Change from previous close: +0.70%Absolute change: +€0.28
In the fiscal year ended December 2025, Fresenius Medical Care reported revenue of €19.63B (+1.51% year over year). Net income was €978.37M, a net margin of 5.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +1.51%
- 2025 vs 2024
- Net income growth
- +81.88%
- 2025 vs 2024
- Net margin
- 5.0%
- 2024: 2.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 2,681 | 2,386 | 2,629 | 2,167 | 2,489 |
| Depreciation and amortization | 1,400 | 1,483 | 1,613 | 1,720 | 1,585 |
| Capital expenditure | -915 | -699 | -685 | -724 | -854 |
| Investing cash flow | -723 | -84.9 | -544 | -735 | -1,196 |
| Financing cash flow | -1,403 | -2,569 | -1,859 | -1,617 | -1,024 |
| Dividends paid | -423 | -349 | -329 | -396 | -392 |
| Share repurchases | -585 | 0.0 | 0.0 | 0.0 | — |
| Debt issued | 1,779 | 146 | 483 | 1,799 | 3,048 |
| Debt repaid | -1,629 | -2,075 | -1,742 | -2,822 | -3,407 |
| Effect of exchange rates | -141 | 26.2 | -72.6 | -23.2 | 131 |
| Net change in cash | 414 | -242 | 153 | -208 | 400 |
| Free cash flow | 1,766 | 1,687 | 1,944 | 1,443 | 1,635 |
| Levered free cash flow | 1,556 | 2,031 | 1,312 | 1,023 | 1,697 |